GlassScriptPhysician profile
Christopher B Dickerson
NPI 1629242896
$2,146.08
in general payments reported to CMS, 2019-2025
10 companies · $596 in 2025
The $596 reported for 2025 was more than what 81% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $395 · 2020: $62.92 · 2021: $186 · 2022: $54.52 · 2023: $272 · 2024: $579 · 2025: $596.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,420 · Gift: $27.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,420.10 |
| Gift | $27.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $933.51 | 2024-2025 | |
| Zimmer Biomet Holdings, INC. | $487.75 | 2019-2021 | |
| Zimvie INC. | $415.02 | 2023-2025 | |
| Geistlich Pharma, North America, INC. | $71.05 | 2020-2024 | Geistlich Bio-Gide, Bio-Materials |
| Depuy Synthes Sales INC. | $59.86 | 2021 | |
| Biohorizons Implant Systems INC. | $56.16 | 2022-2024 | Biohorizons |
| Dentsply Sirona INC | $45.36 | 2021 | |
| Nobel Biocare USA | $35.34 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $22.38 | 2023 | Exparel |
| Keystone Dental INC. | $19.65 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Dickerson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.